BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15374634)

  • 1. CYP1B1 expression in prostate is higher in the peripheral than in the transition zone.
    Ragavan N; Hewitt R; Cooper LJ; Ashton KM; Hindley AC; Nicholson CM; Fullwood NJ; Matanhelia SS; Martin FL
    Cancer Lett; 2004 Nov; 215(1):69-78. PubMed ID: 15374634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
    Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
    Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
    Tokizane T; Shiina H; Igawa M; Enokida H; Urakami S; Kawakami T; Ogishima T; Okino ST; Li LC; Tanaka Y; Nonomura N; Okuyama A; Dahiya R
    Clin Cancer Res; 2005 Aug; 11(16):5793-801. PubMed ID: 16115918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue.
    Williams JA; Martin FL; Muir GH; Hewer A; Grover PL; Phillips DH
    Carcinogenesis; 2000 Sep; 21(9):1683-9. PubMed ID: 10964100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.
    John K; Ragavan N; Pratt MM; Singh PB; Al-Buheissi S; Matanhelia SS; Phillips DH; Poirier MC; Martin FL
    Prostate; 2009 Apr; 69(5):505-19. PubMed ID: 19143007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites.
    Martin FL; Patel II; Sozeri O; Singh PB; Ragavan N; Nicholson CM; Frei E; Meinl W; Glatt H; Phillips DH; Arlt VM
    Prostate; 2010 Oct; 70(14):1586-99. PubMed ID: 20687231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
    Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
    Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines.
    Szaefer H; Licznerska B; Krajka-Kuźniak V; Bartoszek A; Baer-Dubowska W
    Nutr Cancer; 2012 Aug; 64(6):879-88. PubMed ID: 22716309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments.
    Roos PH; Belik R; Föllmann W; Degen GH; Knopf HJ; Bolt HM; Golka K
    Arch Toxicol; 2006 Jan; 80(1):45-52. PubMed ID: 16341845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
    Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
    Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
    Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
    Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intriguing location of myeloperoxidase in the prostate: a preliminary immunohistochemical study.
    Roumeguère T; Delree P; Van Antwerpen P; Rorive S; Vanhamme L; de Ryhove Lde L; Serteyn D; Wespes E; Vanhaerverbeek M; Boudjeltia KZ
    Prostate; 2012 Apr; 72(5):507-13. PubMed ID: 21739466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients.
    Wu MF; Wu WJ; Chang GC; Chen CY; Hu SW; Tsai WT; Lee H; Lin P
    Toxicol Lett; 2004 Apr; 150(2):211-9. PubMed ID: 15093676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, localization and activity of neutral endopeptidase in cultured cells of benign prostatic hyperplasia and prostate cancer.
    Albrecht M; Gillen S; Wilhelm B; Doroszewicz J; Aumüller G
    J Urol; 2002 Jul; 168(1):336-42. PubMed ID: 12050566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium.
    Singh MN; Stringfellow HF; Taylor SE; Ashton KM; Ahmad M; Abdo KR; El-Agnaf OM; Martin-Hirsch PL; Martin FL
    Mol Hum Reprod; 2008 Nov; 14(11):655-63. PubMed ID: 18849443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue.
    Carnell DM; Smith RE; Daley FM; Barber PR; Hoskin PJ; Wilson GD; Murray GI; Everett SA
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):500-9. PubMed ID: 14751521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.